Key focus areas include hit finding and hit validation strategies, access to difficult target classes, cell-based receptor/ligand interactions particularly orphan receptors, non-invasive cell proliferation and in vitro cytotoxicity testing; and antibody and small molecule affinity and kinetic analysis and QSAR.